Tenax Therapeutics
TENX
9 hedge funds and large institutions have $876K invested in Tenax Therapeutics in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
10% less funds holding
Funds holding: 10 → 9 (-1)
50% less capital invested
Capital invested by funds: $1.75M → $876K (-$871K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$199K |
| 2 |
Renaissance Technologies
New York
|
+$146K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$10.5K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $342K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $332K | +$146K | +83 | +30% |
|
|
AC
3
Armistice Capital
New York
| $104K | +$199K | +113 | New |
|
|
FWP
4
FAS Wealth Partners
Leawood,
Kansas
| $33K | – | – | – |
|
5
Bank of New York Mellon
New York
| $20K | – | – | – |
|
|
SM
6
Sabby Management
Miami Beach,
Florida
| $19K | -$10.5K | -6 | -22% |
|
7
Geode Capital Management
Boston,
Massachusetts
| $18K | – | – | – |
|
8
Vanguard Group
Malvern,
Pennsylvania
| $7K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $1K | +$1.76K | +1 | New |
|
|
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$2K | -1 | Closed |
|
TENX Hedge Fund Activity: Q1 2020 in Review
9 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2020, worth a combined $876K — down 50% from $1.75M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TENX positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $199K. The largest seller was Sabby Management, cutting an estimated $10.5K.
- 9 institutional investors held Tenax Therapeutics (TENX) as of Q1 2020, down from 10 in Q4 2019.
- Funds reported $876K of Tenax Therapeutics stock for Q1 2020, down 50% quarter-over-quarter.
- 2 funds opened new Tenax Therapeutics positions in Q1 2020 and 1 closed out, a net change of +1 holder.
- The largest Tenax Therapeutics buyer in Q1 2020 was Armistice Capital, an estimated $199K added.
- The largest Tenax Therapeutics seller in Q1 2020 was Sabby Management, an estimated $10.5K sold.
Based on aggregated 13F filings for Q1 2020.